She asks: “Lupus symptoms can spread to other areas, and I have clients that also still develop other autoimmune diseases. Is this because the dose [of hydroxychloroquine] is too low to treat more effectively, so raising the dose would be helpful? Or would adding ivermectin be of greater benefit?” What is Creator’s perspective?

It is important, always, to stay within safe dose ranges as the problem is more likely the need for more time to complete the healing than for a higher dose level being truly needed. With a problem of this kind there are advantages in multi-agent therapy, given the nature of the problem being a difficult one in terms of its insidious nature and persistence, and the inner roadblocks within the client's own makeup that can delay things. Hydroxychloroquine and ivermectin do work well together, having overlapping but somewhat unique mechanistic benefits.